Development of all-in-one CRISPR/Cas9 and CRISPRi AAV constructs to treat autosomal dominant retinitis pigmentosa
<p>Dominant mutations in RHO (rhodopsin) are the most common cause of autosomal dominant retinitis pigmentosa (RHO-adRP). RHO-adRP causes progressive loss of rod cells, followed by cone cells, leading to blindness. This disease is a candidate for CRISPR gene editing, as reduction of mutant rho...
Autor principal: | Peddle, CF |
---|---|
Altres autors: | MacLaren, RE |
Format: | Thesis |
Idioma: | English |
Publicat: |
2021
|
Matèries: |
Ítems similars
-
Rhodopsin mutations are scarcely implicated in autosomal recessive retinitis pigmentosa: A preliminary study of Egyptian retinitis pigmentosa patients
per: Reem Mebed, et al.
Publicat: (2015-10-01) -
AAV-CRISPR/Cas9 Gene Editing Preserves Long-Term Vision in the P23H Rat Model of Autosomal Dominant Retinitis Pigmentosa
per: Saba Shahin, et al.
Publicat: (2022-04-01) -
Herencia de la retinosis pigmentaria en la provincia Camagüey Inheritance of retinitis pigmentosa in the province of Camagüey
per: Elisa Dyce Gordon, et al.
Publicat: (1999-06-01) -
Whole exome sequencing reveals novel EYS mutations in Chinese patients with autosomal recessive retinitis pigmentosa
per: Xiaoqiang Xiao, et al.
Publicat: (2019-01-01) -
Genetic dissection of non-syndromic retinitis pigmentosa
per: Aarti Bhardwaj, et al.
Publicat: (2022-01-01)